These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18494813)

  • 1. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study).
    Barnett AH; Krentz AJ; Strojek K; Sieradzki J; Azizi F; Embong M; Imamoglu S; Perusicová J; Uliciansky V; Winkler G
    Diabetes Obes Metab; 2008 Dec; 10(12):1239-47. PubMed ID: 18494813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glargine insulin/gliclazide MR combination therapy is more effective than premixed insulin monotherapy in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs.
    Zhou J; Zheng F; Guo X; Yang H; Zhang M; Tian H; Guo L; Li Q; Mo Y; Jia W
    Diabetes Metab Res Rev; 2015 Oct; 31(7):725-33. PubMed ID: 25952634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Self-Monitoring Blood Glucose on Glycaemic Control Among Insulin-Treated Patients With Diabetes Mellitus in Northeastern Tanzania: A Randomised Controlled Trial.
    Muhali SS; Muhali FS; Mfinanga SG; Sadiq AM; Marandu AA; Kyala NJ; Said FH; Nziku EB; Mirai TE; Ngocho JS; Mlay HL; Waria GG; Chambega A; Kessy SN; Kilonzo KG; Lyamuya FS; Mkwizu EW; Shao ER; Chamba NG
    J Diabetes Res; 2024; 2024():6789672. PubMed ID: 38899147
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of glycaemic control over 1 year with pioglitazone or gliclazide in patients with Type 2 diabetes.
    Perriello G; Pampanelli S; Di Pietro C; Brunetti P;
    Diabet Med; 2006 Mar; 23(3):246-52. PubMed ID: 16492206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelations between diabetes therapy, self-monitoring of blood glucose, blood glucose and non-fatal or fatal endpoints in patients with type 2 diabetes / results of a longitudinal cohort study (ROSSO 5).
    Schneider B; Martin S; Heinemann L; Lodwig V; Kolb H
    Arzneimittelforschung; 2007; 57(12):762-9. PubMed ID: 18380408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of self-monitoring of blood glucose versus retrospective continuous glucose monitoring in improving glycaemic control in diabetic kidney disease patients.
    Yeoh E; Lim BK; Fun S; Tong J; Yeoh LY; Sum CF; Subramaniam T; Lim SC
    Nephrology (Carlton); 2018 Mar; 23(3):264-268. PubMed ID: 27933715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, controlled trial of self-monitoring of blood glucose in patients with type 2 diabetes receiving conventional insulin treatment.
    Nauck MA; Haastert B; Trautner C; Müller UA; Nauck MA; Heinemann L;
    Diabetologia; 2014 May; 57(5):868-77. PubMed ID: 24445534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone.
    Ristic S; Collober-Maugeais C; Pecher E; Cressier F
    Diabet Med; 2006 Jul; 23(7):757-62. PubMed ID: 16842480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliclazide modified release: results of a 2-year study in patients with type 2 diabetes.
    Drouin P; Standl E;
    Diabetes Obes Metab; 2004 Nov; 6(6):414-21. PubMed ID: 15479217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of lowering glycated haemoglobin with a gliclazide modified release-based intensive glucose lowering regimen in the ADVANCE trial.
    Zoungas S; Chalmers J; Kengne AP; Pillai A; Billot L; de Galan B; Marre M; Neal B; Harrap S; Poulter N; Patel A
    Diabetes Res Clin Pract; 2010 Aug; 89(2):126-33. PubMed ID: 20541825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structured self-monitoring of blood glucose regimens improve glycemic control in poorly controlled Chinese patients on insulin therapy: Results from COMPASS.
    Ji L; Su Q; Feng B; Shan Z; Hu R; Xing X; Xue Y; Yang T; Hua Y
    J Diabetes; 2017 May; 9(5):495-501. PubMed ID: 27249791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between self-monitoring of blood glucose and glycaemic control among patients attending an urban diabetes clinic in Nigeria.
    Iwuala SO; Olamoyegun MA; Sabir AA; Fasanmade OA
    Ann Afr Med; 2015; 14(4):182-7. PubMed ID: 26470743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time spent in target range assessed by self-monitoring blood glucose associates with glycated hemoglobin in insulin treated patients with diabetes.
    Cutruzzolà A; Irace C; Parise M; Fiorentino R; Pio Tripodi PF; Ungaro S; Babinsky V; Gnasso A
    Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1800-1805. PubMed ID: 32669240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-monitoring of Blood Glucose in Non-Insulin Treated Type 2 Diabetes (The SMBG Study): study protocol for a randomised controlled trial.
    Parsons S; Luzio S; Bain S; Harvey J; McKenna J; Khan A; Rice S; Watkins A; Owens DR
    BMC Endocr Disord; 2017 Jan; 17(1):4. PubMed ID: 28143495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial.
    Farmer AJ; Wade AN; French DP; Simon J; Yudkin P; Gray A; Craven A; Goyder L; Holman RR; Mant D; Kinmonth AL; Neil HA;
    Health Technol Assess; 2009 Feb; 13(15):iii-iv, ix-xi, 1-50. PubMed ID: 19254484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of gliclazide with insulin as initial treatment modality in newly diagnosed type 2 diabetes.
    Chandra ST; Priya G; Khurana ML; Jyotsna VP; Sreenivas V; Dwivedi S; Ammini AC
    Diabetes Technol Ther; 2008 Oct; 10(5):363-8. PubMed ID: 18715212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mobile phone application combined with or without self-monitoring of blood glucose on glycemic control in patients with diabetes: A randomized controlled trial.
    Yu Y; Yan Q; Li H; Li H; Wang L; Wang H; Zhang Y; Xu L; Tang Z; Yan X; Chen Y; He H; Chen J; Feng B
    J Diabetes Investig; 2019 Sep; 10(5):1365-1371. PubMed ID: 30815973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs-a multi-centre, randomized controlled trial.
    Scherbaum WA; Ohmann C; Abholz HH; Dragano N; Lankisch M
    PLoS One; 2008 Aug; 3(8):e3087. PubMed ID: 18769484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1c and high incidence of hypoglycaemia.
    Oei E; Samad N; Visser A; Chowdhury TA; Fan SL
    Diabet Med; 2016 Sep; 33(9):e17-20. PubMed ID: 26470840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.